| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | PF868554 | |
| 3 | Generic Name | filibuvir | |
| 4 | Indication | Hepatitis C | |
| 5 | Clinical Trials | ||
| 6 | Phase II 8-day study | ||
| 7 | n=6 per cohort: 100mg, 300mg or 450mg BID or 300mg TID | ||
| 8 | These cohorts resulted in 0.97log 1.84log 1.74log and 2.13log reductions. | ||
| 9 | |||
| 10 | http://www.natap.org/2009/EASL/EASL_34.htm |